Human Anti-TNF Monoclonal Antibody Adalimumab in Canadian Subjects With Moderate to Severe Crohn's Disease (ACCESS)

NCT00427921 · clinicaltrials.gov ↗
PHASE3
Phase
COMPLETED
Status
304
Enrollment
INDUSTRY
Sponsor class

Conditions

Interventions

Sponsor

Abbott